| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
1 Departments of Pathology, 2 Urology, and 3 Neurosurgery, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, and 4 Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia
Melanoma differentiation associated gene-7/interleukin-24 (Mda-7/IL-24), a novel member of the IL-10 family of cytokines, uniquely displays cancer-specific apoptosis-inducing activity. Positive results in ongoing phase I/II clinical trials have strengthened the possibility of its utilization as a cancer gene therapeutic. Previous studies document that signaling events leading to Ad.mda-7-induced transformed cell apoptosis are tyrosine kinase-independent. These results suggest that mda-7/IL-24 cancer cell-specific activity could occur through mechanisms independent of binding to its currently recognized cognate receptors and might even occur independent of receptor function. An adenovirus vector expressing a nonsecreted version of MDA-7/IL-24 protein was generated via deletion of its signal peptide. This nonsecreted protein was as effective as wild-type secreted MDA-7/IL-24 in inducing apoptosis in prostate carcinoma cell lines and displayed transformed cell specificity and localization of MDA-7/IL-24 in the Golgi/endoplasmic reticulum compartments. Our results indicate that mda-7/IL-24-mediated apoptosis can be triggered through a combination of intracellular as well as secretory mechanisms and can occur efficiently in the absence of protein secretion.
This article has been cited by other articles:
![]() |
M. Sakaguchi, K. Kataoka, F. Abarzua, R. Tanimoto, M. Watanabe, H. Murata, S. S. Than, K. Kurose, Y. Kashiwakura, K. Ochiai, et al. Overexpression of REIC/Dkk-3 in Normal Fibroblasts Suppresses Tumor Growth via Induction of Interleukin-7 J. Biol. Chem., May 22, 2009; 284(21): 14236 - 14244. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sahoo, Y. M. Jung, H.-K. Kwon, H.-J. Yi, S. Lee, S. Chang, Z.-Y. Park, K.-C. Hwang, and S.-H. Im A Novel Splicing Variant of Mouse Interleukin (IL)-24 Antagonizes IL-24-induced Apoptosis J. Biol. Chem., October 24, 2008; 283(43): 28860 - 28872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sauane, Z.-z. Su, P. Gupta, I. V. Lebedeva, P. Dent, D. Sarkar, and P. B. Fisher Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis PNAS, July 15, 2008; 105(28): 9763 - 9768. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sauane, P. Gupta, I. V. Lebedeva, Z.-z. Su, D. Sarkar, A. Randolph, K. Valerie, R. V. Gopalkrishnan, and P. B. Fisher N-Glycosylation of MDA-7/IL-24 Is Dispensable for Tumor Cell-Specific Apoptosis and "Bystander" Antitumor Activity Cancer Res., December 15, 2006; 66(24): 11869 - 11877. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gupta, M. R. Walter, Z.-z. Su, I. V. Lebedeva, L. Emdad, A. Randolph, K. Valerie, D. Sarkar, and P. B. Fisher BiP/GRP78 Is an Intracellular Target for MDA-7/IL-24 Induction of Cancer-Specific Apoptosis Cancer Res., August 15, 2006; 66(16): 8182 - 8191. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. Lebedeva, D. Sarkar, Z.-Z. Su, R. V. Gopalkrishnan, M. Athar, A. Randolph, K. Valerie, P. Dent, and P. B. Fisher Molecular Target-Based Therapy of Pancreatic Cancer Cancer Res., February 15, 2006; 66(4): 2403 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Fisher Is mda-7/IL-24 a "Magic Bullet" for Cancer? Cancer Res., November 15, 2005; 65(22): 10128 - 10138. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Abarzua, M. Sakaguchi, M. Takaishi, Y. Nasu, K. Kurose, S. Ebara, M. Miyazaki, M. Namba, H. Kumon, and N.-h. Huh Adenovirus-Mediated Overexpression of REIC/Dkk-3 Selectively Induces Apoptosis in Human Prostate Cancer Cells through Activation of c-Jun-NH2-Kinase Cancer Res., November 1, 2005; 65(21): 9617 - 9622. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sarkar, Z.-z. Su, N. Vozhilla, E. S. Park, P. Gupta, and P. B. Fisher Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice PNAS, September 27, 2005; 102(39): 14034 - 14039. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishikawa, T. Nakagawa, R. Miyahara, Y. Kawano, K. Takenaka, K. Yanagihara, Y. Otake, H. Katakura, H. Wada, and F. Tanaka Expression of MDA-7/IL-24 and Its Clinical Significance in Resected Non-Small Cell Lung Cancer Clin. Cancer Res., February 1, 2005; 11(3): 1198 - 1202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |